His primary areas of study are Stroke, Internal medicine, Surgery, Thrombolysis and Odds ratio. His Stroke research incorporates themes from Prospective cohort study, Magnetic resonance imaging and Perfusion scanning. He combines subjects such as Gastroenterology and Cardiology with his study of Internal medicine.
His research integrates issues of Patent foramen ovale and Migraine in his study of Surgery. His Thrombolysis study combines topics in areas such as Tissue plasminogen activator, Fibrinolytic agent, Radiology and Clinical trial. His Odds ratio research is multidisciplinary, relying on both Genome-wide association study, Bioinformatics and Confidence interval.
Vincent Thijs mainly focuses on Stroke, Internal medicine, Cardiology, Surgery and Thrombolysis. His work carried out in the field of Stroke brings together such families of science as Neurology, Magnetic resonance imaging and Physical therapy. Odds ratio, Atrial fibrillation, Confidence interval, Meta-analysis and Brain ischemia are the core of his Internal medicine study.
His research investigates the link between Odds ratio and topics such as Genome-wide association study that cross with problems in Bioinformatics and Genetic association. His studies in Cardiology integrate themes in fields like Patent foramen ovale, Randomized controlled trial and Ischemic stroke. His Thrombolysis study combines topics from a wide range of disciplines, such as Tissue plasminogen activator, Fibrinolytic agent, Perfusion scanning and Clinical trial.
Vincent Thijs mainly investigates Stroke, Internal medicine, Cardiology, Modified Rankin Scale and Thrombolysis. While the research belongs to areas of Stroke, Vincent Thijs spends his time largely on the problem of Randomized controlled trial, intersecting his research to questions surrounding Tenecteplase, Anesthesia and Prospective cohort study. His Internal medicine study frequently intersects with other fields, such as Neurology.
He has researched Cardiology in several fields, including Patent foramen ovale, Venous thrombosis and Ischaemic stroke. His research on Modified Rankin Scale also deals with topics like
Stroke, Internal medicine, Modified Rankin Scale, Cardiology and Thrombolysis are his primary areas of study. His Stroke research incorporates themes from Emergency medical services, Randomized controlled trial, Meta-analysis, Magnetic resonance imaging and Stenosis. His Internal medicine study integrates concerns from other disciplines, such as Genome-wide association study and Hyperintensity.
His Modified Rankin Scale research integrates issues from Brain ischemia and Surgery, Retrospective cohort study. His Cardiology research includes elements of Heart rate variability and Neurology. The Thrombolysis study combines topics in areas such as Reperfusion therapy, Cerebral infarction, Fibrinolytic agent, Perfusion scanning and Tissue plasminogen activator.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Cryptogenic stroke and underlying atrial fibrillation
Tommaso Sanna;Hans-Christoph Diener;Rod S. Passman;Richard A. Bernstein.
The New England Journal of Medicine (2014)
Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study.
Gregory W. Albers;Vincent N. Thijs;Lawrence Wechsler;Stephanie Kemp.
Annals of Neurology (2006)
Analysis of shared heritability in common disorders of the brain
Verneri Anttila;Verneri Anttila;Brendan Bulik-Sullivan;Brendan Bulik-Sullivan;Hilary K. Finucane;Raymond K. Walters;Raymond K. Walters.
Science (2018)
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis
Ashley H. Beecham;Nikolaos A. Patsopoulos;Nikolaos A. Patsopoulos;Dionysia K. Xifara;Mary F. Davis.
Nature Genetics (2013)
VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death
Diether Lambrechts;Erik Storkebaum;Masafumi Morimoto;Jurgen Del-Favero.
Nature Genetics (2003)
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
Götz Thomalla;Claus Z. Simonsen;Florent Boutitie;Grethe Andersen.
The New England Journal of Medicine (2018)
Treatment and outcomes of acute basilar artery occlusion in the Basilar Artery International Cooperation Study (BASICS): a prospective registry study.
Wouter J. Schonewille;Christine A. C. Wijman;Patrik Michel;Christina M. Rueckert.
Lancet Neurology (2009)
The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial
Else Charlotte Sandset;Else Charlotte Sandset;Philip M. W. Bath;Gudrun Boysen;Dalius Jatuzis.
The Lancet (2011)
Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE collaboration): a meta-analysis of genome-wide association studies.
Matthew Traylor;Martin Farrall;Elizabeth G Holliday;Cathie Sudlow.
Lancet Neurology (2012)
Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
Bruce C.V. Campbell;Peter J. Mitchell;Leonid Churilov;Nawaf Yassi.
The New England Journal of Medicine (2018)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Gothenburg
Harvard University
John Hunter Hospital
University of Maryland, Baltimore
Mayo Clinic
University Hospital of Basel
Deakin University
University of Maryland, Baltimore
Stanford University
University of Oxford
University College London
University of Queensland
University of Strasbourg
University of Pennsylvania
Skidaway Institute of Oceanography
Emory University
University of Oklahoma
Oklahoma State University Center for Health Sciences
Boys Town
University of Colorado Boulder
Children's Hospital of Philadelphia
University of Bari Aldo Moro
Boston University
Edinburgh Napier University
Ministry of Public Health
National Institute for Nuclear Physics